Shares of Genedrive PLC (LON: GDR) have been stuck trading sideways since mid-June as investors patiently wait for updates regarding its Q2 earnings.
Many investors are waiting for a trading update from Genederive after companies such as Danaher, Beckman Coulter Life Sciences’ parent company, recently reported earnings.
Genedrive has a supply agreement with Beckman Coulter, which reported that revenues from its diagnostics division rose 41% to reach $2.31 billion compared to the $1.66 billion reported last year.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Danaher’s results left many wondering what percentage of their sales could be attributed to sales of Genedrive’s COVID-19 test kit within the United States.
Investors are also eagerly waiting to see how quickly Genedrive can complete the testing of its new COVID-19 Point of Care (PoC) device that can detect multiple variants of the coronavirus amid rising concerns over the effectiveness of the available COVID-19 vaccines.
However, investors might have to wait a bit longer for Genedirve to release its Q2 earnings results since the company has not indicated when it will release its Q2 report.
In the meantime, Genedrive shares are likely to remain under selling pressure until the Q2 results are released, which could be an excellent trade setup for aggressive traders.
However, traders should be aware that a negative earnings report could trigger a deeper selloff and use a stop-loss order to protect themselves from significant losses.
*This is not investment advice.
Genedrive share price.
Genedrive shares have been trading sideways since mid-June as investors wait for Q2 results.
